To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Statins and muscle pain
NEMA Research, Inc., Naples, FL, USA.
Department of Medical and Surgical Sciences and Biotechnologies, Unit of Anaesthesia, Intensive Care and Pain Medicine, Sapienza University of Rome, Rome, Italy.
NEMA Research, Inc., Naples, FL, USA; Colucci & Associates, LLC, Newtown, Connecticut, USA.
Centre for Research and Development, Region Gävleborg/Uppsala University, Gävle, Sweden.
Show others and affiliations
2020 (English)In: Expert Review of Clinical Pharmacology, ISSN 1751-2433, E-ISSN 1751-2441, Vol. 13, no 3, p. 299-310Article, review/survey (Refereed) Published
Abstract [en]

Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone in the prevention of cardiovascular disease. However, muscle symptoms are often reported from patients on statins. Muscle symptoms are frequently reported as adverse events associated with statin therapy.

Areas covered: In the present narrative review, statin-associated muscle pain is discussed. It elucidates potential mechanisms and possible targets for management.

Expert opinion: In general, the evidence in support of muscle pain caused by statins is in some cases equivocal and not particularly strong. Reported symptoms are difficult to quantify. Rarely is it possible to establish a causal link between statins and muscle pain. In randomized controlled trials, statins are well tolerated, and muscle-pain related side-effects is similar to placebo. There are also nocebo effects of statins. Exchange of statin may be beneficial although all statins have been associated with muscle pain. In some patients reduction of dose is worth trying, especially in primary prevention Although the benefits of statins outweigh potential risks in the vast majority of cases, careful clinical judgment may be necessary in certain cases to manage potential side effects on an individual basis.

Place, publisher, year, edition, pages
Expert Reviews Ltd. , 2020. Vol. 13, no 3, p. 299-310
Keywords [en]
Adverse events, cardiovascular disease, statin, muscle pain, myalgia, side effects
National Category
Pharmacology and Toxicology Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:oru:diva-122186DOI: 10.1080/17512433.2020.1734451ISI: 000517168500001PubMedID: 32089020Scopus ID: 2-s2.0-85080113772OAI: oai:DiVA.org:oru-122186DiVA, id: diva2:1979489
Available from: 2025-06-30 Created: 2025-06-30 Last updated: 2026-01-23Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Magnusson, Peter

Search in DiVA

By author/editor
Al-Saadi, JonathanMagnusson, Peter
In the same journal
Expert Review of Clinical Pharmacology
Pharmacology and ToxicologyCardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 7 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf